| 발표일자: |
2016년 11월 4일(금) ~ 11월 6일(일) |
| 발표번호: |
P(판넬)-017 |
| 발표장소: |
킨텍스 제2전시장 7B홀 |
|
|
| 안구내 염증 발현이 없는 베체트병 환자에서 무증상 안구내 및 전신염증의 지표로서의 황반하 맥락막두께 측정 |
| (1) 아주대학교 의과대학 안과학교실, (2) 아주대학교 의과대학 피부과학교실 |
| 최신영(1), 정유리(1), 장세란(1), 이은소(2), 이기황(1) |
|
목적 : To investigate whether subfoveal choroidal thickness, measured using enhanced depth imaging optical coherence tomography (EDI-OCT), is an indicator of subclinical ocular or systemic inflammation in eyes with Behçet’s disease (BD) without active ocular inflammation.
방법 : Clinical features of non-uveitic patients with BD (NUBD group), patients with a previous history of Behçet’s uveitis in an inactive state (IUBD group), and healthy controls evaluated from October 2014 to September 2015 were analyzed retrospectively. Subfoveal choroidal thickness was measured using EDI-OCT.
결과 : The NUBD group included 46 eyes in 24 patients; the IUBD group included 18 eyes in 12 patients; and the control group included 35 eyes in 23 individuals. Mean subfoveal choroidal thicknesses differed significantly among these groups. Choroidal thickness was significantly greater in the NUBD (297.4 ± 81.0 μm) than in the IUBD (253.0 ± 77.2 μm) and control (261.2 ± 78.6 μm) groups. Disease activity score was significantly higher in the NUBD than in the IUBD group, while the use of cyclosporine was significantly associated with choroidal thickness in eyes with NUBD.
결론 : Subfoveal choroidal thickness, as measured by EDI-OCT, may be a clinical indicator of subclinical ocular inflammation and systemic inflammation in BD patients without active ocular inflammation.
|
| |